Benzinga | Aug 7, 2020 11:33AM EDT

SVB Leerink Maintains Outperform on Replimune Group, Raises Price Target to $27

SVB Leerink analyst Jonathan Chang maintains Replimune Group (NASDAQ:REPL) with a Outperform and raises the price target from $25 to $27.